Study #2020-0673
Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer
MD Anderson Study Status
Not Accepting
Treatment Agent
Description
This clinical trial studies the effects of a dietary intervention prior to surgery (neoadjuvant) in patients with intermediate risk prostate cancer. Changing your diet before surgery may help to improve overall health. Information from this study may help researchers better understand the influence of diet on the outcomes of patients with intermediate prostate cancer.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Prostate Adenocarcinoma;Stage I Prostate Cancer AJCC v8;Stage II Prostate Cancer AJCC v8;Stage IIA Prostate Cancer AJCC v8;Stage IIB Prostate Cancer AJCC v8;Stage IIC Prostate Cancer AJCC v8;Stage IIIA Prostate Cancer AJCC v8
Study phase:
Not applicable
Physician name:
Justin Gregg
Department:
Urology
For general questions about clinical trials:
1-833-731-1107
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.